NEURODEGENERATIVE DISEASES
Clinical trials for NEURODEGENERATIVE DISEASES explained in plain language.
Never miss a new study
Get alerted when new NEURODEGENERATIVE DISEASES trials appear
Sign up with your email to follow new studies for NEURODEGENERATIVE DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Neurodegenerative drug study ends early: what happened?
Disease control TerminatedThis study aimed to give continued access to the experimental drug latozinemab for people with neurodegenerative diseases who had already taken it in a previous study. Only 17 participants were enrolled before the study was terminated early. The main goals were to track how long …
Matched conditions: NEURODEGENERATIVE DISEASES
Phase: PHASE3 • Sponsor: Alector Inc. • Aim: Disease control
Last updated May 26, 2026 08:34 UTC
-
Alzheimer's drug study halted early: what happened?
Disease control TerminatedThis study looked at the long-term safety and effects of a drug called XPro1595 in people with Alzheimer's disease who had already taken it in earlier studies. Only 11 people took part, and the study was stopped early. The main goal was to check for side effects and see if the dr…
Matched conditions: NEURODEGENERATIVE DISEASES
Phase: PHASE2 • Sponsor: Inmune Bio, Inc. • Aim: Disease control
Last updated May 20, 2026 11:56 UTC